about
Intrahepatic cholestasis of pregnancyLiver diseases in pregnancy: diseases unique to pregnancyOsteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implicationsEthinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liverClues to understanding the oxidation of estradiol in humans: effects of acute infectious hepatitis, autoimmune hepatitis, and chronic liver disease.Genetics of familial intrahepatic cholestasis syndromes.Intra-hepatic Cholestasis of Pregnancy: A Comprehensive Review.Protective effect of Jasonia montana against ethinylestradiol-induced cholestasis in ratsIntrahepatic cholestasis of pregnancy-current achievements and unsolved problemsGenetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.Immunology of hepatic diseases during pregnancy.Cholestatic properties and hepatic transport of steroid glucuronides.Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat.Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.Influence of oral contraceptives on fasting gallbladder volume.Effect of epomediol on ethinyloestradiol-induced changes in bile acid and cholesterol metabolism in rats.Progressive cholestatic liver disease associated with clarithromycin treatment.Effects of epomediol on ethinyloestradiol-induced changes in glutathione homeostasis in the rat.Sex hormonal preparations and the liver.
P2860
Q21202971-3FE8904D-E849-4BBC-BE32-45F65A9AF77AQ24596588-29B507E6-6FA4-4522-8CBD-BCBF414836B2Q26824690-25FE7EA9-32AB-4FC7-8AF2-E9DE709F5A57Q28378723-6F5DD505-8E31-4358-B292-4C0C6A285A57Q34671102-5560AB51-6C33-42AA-8252-96B77AC1B96CQ35448570-13E34B78-7268-4D8A-81C7-0775AF884C54Q37054384-339BBCC7-F0E6-4F05-A62A-D059D6D5F59CQ37063359-0C466AA0-1FC3-4CB3-9DD3-BDB46CD133E2Q37294587-1367163E-4DE9-4020-BBE7-FA64330E5DC3Q37841614-27B22A2B-D63A-4C9B-9E28-26CC9B82CAB8Q38870963-955238F5-A86C-49E3-A705-FBB2A984C067Q41501828-6EC9EDFA-EA11-4FE2-A260-A262743D9C43Q42541211-585B1B7D-67E8-430F-B053-EAD3AFC388FAQ42545117-66AC84AA-BE9F-4B3E-81C8-5708FFD1E170Q43328067-BAF1765D-B622-4E8D-B8EC-3BD2BBA54925Q43688232-7AF69B10-4F07-4360-AFAC-FDB6E4B23666Q44013980-B31E6807-8EEE-4773-B303-7013885115A2Q44032577-55D44BDB-D806-4420-9B29-896B252379E4Q50874278-E5847F08-859B-43AB-A068-714AD1373C20
P2860
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Female sex steroids and cholestasis
@ast
Female sex steroids and cholestasis
@en
Female sex steroids and cholestasis
@nl
type
label
Female sex steroids and cholestasis
@ast
Female sex steroids and cholestasis
@en
Female sex steroids and cholestasis
@nl
prefLabel
Female sex steroids and cholestasis
@ast
Female sex steroids and cholestasis
@en
Female sex steroids and cholestasis
@nl
P356
P1476
Female sex steroids and cholestasis
@en
P2093
P356
10.1055/S-2008-1040559
P407
P577
1987-02-01T00:00:00Z